These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611 [TBL] [Abstract][Full Text] [Related]
8. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. Ludwig GV; Turell MJ; Vogel P; Kondig JP; Kell WK; Smith JF; Pratt WD Am J Trop Med Hyg; 2001; 64(1-2):49-55. PubMed ID: 11425162 [TBL] [Abstract][Full Text] [Related]
13. Environmental hazard assessment of Venezuelan equine encephalitis virus vaccine candidate strain V3526. Rao V; Hinz ME; Roberts BA; Fine D Vaccine; 2004 Jun; 22(20):2667-73. PubMed ID: 15193393 [TBL] [Abstract][Full Text] [Related]
14. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice. Steele KE; Davis KJ; Stephan K; Kell W; Vogel P; Hart MK Vet Pathol; 1998 Sep; 35(5):386-97. PubMed ID: 9754544 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus. Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL Vaccine; 2010 Apr; 28(18):3143-51. PubMed ID: 20193792 [TBL] [Abstract][Full Text] [Related]
16. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. Pratt WD; Davis NL; Johnston RE; Smith JF Vaccine; 2003 Sep; 21(25-26):3854-62. PubMed ID: 12922119 [TBL] [Abstract][Full Text] [Related]
17. A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV). Fine DL; Jenkins E; Martin SS; Glass P; Parker MD; Grimm B J Virol Methods; 2010 Feb; 163(2):424-32. PubMed ID: 19903494 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB. Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL Vaccine; 2010 Jan; 28(4):1031-40. PubMed ID: 19914193 [TBL] [Abstract][Full Text] [Related]